Evidence map›Paper›PMID 42064055›Full record

ArticleFrontiers in immunology2026

Subunit vaccination using Atomic Layering Thermostable Antigen and Adjuvant (ALTA

Daria L Ivanova, Matthew S Lewis, Annie B Caplan, Isabella R Walters, Emma M Snyder, Keith A Strand, Lorena R Antunez, Sineenart Sengyee, Sarah B Weiby, Federico Urbano-Munoz and 3 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daria L IvanovaVitriVax, Inc., Boulder, CO, United States.
Matthew S LewisVitriVax, Inc., Boulder, CO, United States.
Annie B CaplanVitriVax, Inc., Boulder, CO, United States.
Isabella R WaltersVitriVax, Inc., Boulder, CO, United States.
Emma M SnyderVitriVax, Inc., Boulder, CO, United States.
Keith A StrandVitriVax, Inc., Boulder, CO, United States.
Lorena R AntunezVitriVax, Inc., Boulder, CO, United States.
Sineenart SengyeeDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV, United States.
Sarah B WeibyDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV, United States.
Federico Urbano-MunozDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV, United States.
Mary N BurtnickDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV, United States.
Paul J BrettDepartment of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV, United States.
Sky W BrubakerVitriVax, Inc., Boulder, CO, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Creating effective and thermostable vaccines is of significant relevance for public health. The Atomic Layering Thermostable Antigen and Adjuvant (ALTA

Indexed as

Adjuvants, ImmunologicAdjuvants, VaccineBacterial VaccinesImmunity, CellularImmunity, HumoralVaccines, SubunitAnimalsAntibodies, BacterialAntigens, BacterialBurkholderia pseudomalleiFemaleMiceOvalbuminProtein Subunit VaccinesVaccinationAdjuvants, ImmunologicAdjuvants, VaccineAntibodies, BacterialAntigens, BacterialBacterial VaccinesOvalbuminProtein Subunit VaccinesVaccines, SubunitadjuvantALTA®atomic layer depositionBurkholderia pseudomalleicellular immunitycontrolled releasehumoral immunitysubunit vaccine

Identifiers

PMID42064055
PMCPMC13124971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.